Safety and efficacy of long-term etanercept in the treatment of methotrexate-refractory polyarticular-course juvenile idiopathic arthritis in Japan

Modern Rheumatology

Volumn 22, Issue 5, 2012, Pages 720-726

  Mori, Masaaki ^a   Takei, Syuji ^b   Imagawa, Tomoyuki ^b   Imanaka, Hiroyuki ^c   Nerome, Yasuhito ^b   Higuchi, Rumiko ^c   Kawano, Yoshifumi ^b   Yokota, Shumpei ^c   Sugiyama, Noriko ^d   Yuasa, Hirotoshi ^d   Fletcher, Tracey ^d   Wajdula, Joseph S ^d  

^a YOKOHAMA CITY UNIVERSITY MEDICAL CENTER   (Japan)

^b KAGOSHIMA UNIVERSITY   (Japan)

^c YOKOHAMA CITY UNIVERSITY   (Japan)

^d PFIZER INC   (United States)

Author keywords

Anti TNF agent; Etanercept; Juvenile idiopathic arthritis; Polyarticular course

Indexed keywords

C REACTIVE PROTEIN; CORTICOSTEROID; DISEASE MODIFYING ANTIRHEUMATIC DRUG; ETANERCEPT; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT;

ADOLESCENT; ALLERGIC CONJUNCTIVITIS; ALLERGIC RHINITIS; ARTICLE; BRONCHITIS; CAMPYLOBACTER ENTERITIS; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONSTIPATION; CORTICOSTEROID THERAPY; DENTAL CARIES; DIARRHEA; DISEASE ACTIVITY; DISEASE DURATION; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG SAFETY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ECZEMA; EPISTAXIS; FEMALE; GASTRITIS; GASTROENTERITIS; HEALTH ASSESSMENT QUESTIONNAIRE; HERPES ZOSTER; HUMAN; INFECTION; INFLUENZA; INJECTION SITE BLEEDING; INJECTION SITE REACTION; INTENTION TO TREAT ANALYSIS; JAPAN; JUVENILE RHEUMATOID ARTHRITIS; LONG TERM CARE; MALE; MULTICENTER STUDY; MYALGIA; OPEN STUDY; PATIENT COMPLIANCE; PHARYNGITIS; PRESCHOOL CHILD; PRIORITY JOURNAL; RHINOPHARYNGITIS; SCHOOL CHILD; SELF INJECTION; SKIN ABSCESS; STOMACH DISCOMFORT; STOMATITIS; THORAX PAIN; TREATMENT DURATION; TREATMENT REFUSAL; UPPER RESPIRATORY TRACT INFECTION; URTICARIA;

ADOLESCENT; ANTIRHEUMATIC AGENTS; ARTHRITIS, JUVENILE RHEUMATOID; C-REACTIVE PROTEIN; CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE; DRUG SUBSTITUTION; FEMALE; HEALTH STATUS; HUMANS; IMMUNOGLOBULIN G; MALE; METHOTREXATE; QUALITY OF LIFE; RECEPTORS, TUMOR NECROSIS FACTOR; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84870363509     PISSN: 14397595     EISSN: 14397609     Source Type: Journal    
DOI: 10.1007/s10165-011-0578-5     Document Type: Article

References (18)

1. Petty RE, Southwood TR, Manners P, Baum J, Glass DN, Goldenberg J, et al. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol. 2004;31(2):390-2.
2. Lovell DJ, Giannini EH, Reiff A, Cawkwell GD, Silverman ED, Nocton JJ, et al. Etanercept in children with polyarticular juvenile rheumatoid arthritis. Pediatric Rheumatology Collaborative Study Group. N Engl J Med. 2000;342(11):763-9.
3. Lovell DJ, Reiff A, Ilowite NT, Wallace CA, Chon Y, Lin SL, et al. Safety and efficacy of up to eight years of continuous etanercept therapy in patients with juvenile rheumatoid arthritis. Arthritis Rheum. 2008;58(5):1496-504.
4. Lovell DJ, Ruperto N, Goodman S, Reiff A, Jung L, Jarosova K, et al. Adalimumab with or without methotrexate in juvenile rheumatoid arthritis. N Engl J Med. 2008;359(8):810-20.
5. Horneff G, Ebert A, Fitter S, Minden K, Foeldvari I, Kummerle-Deschner J, et al. Safety and efficacy of once weekly etanercept 0.8 mg/kg in a multicentre 12 week trial in active polyarticular course juvenile idiopathic arthritis. Rheumatology. 2009;48(8): 916-9.
6. Horneff G, De Bock F, Foeldvari I, Girschick HJ, Michels H, Moebius D, et al. Safety and efficacy of combination of etanercept and methotrexate compared to treatment with etanercept only in patients with juvenile idiopathic arthritis (JIA): preliminary data from the German JIA Registry. Ann Rheum Dis. 2009;68(4):519-25.
7. Ruperto N, Lovell DJ, Cuttica R, Wilkinson N, Woo P, Espada G, et al. A randomized, placebo-controlled trial of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritis. Arthritis Rheum. 2007;56(9):3096-106.
8. Ruperto N, Lovell DJ, Cuttica R, Woo P, Meiorin S, Wouters C, et al. Long-Term efficacy and safety of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritis: findings from an open-label treatment extension. Ann Rheum Dis. 2010;69(4):718-22.
9. Ruperto N, Lovell DJ, Quartier P, Paz E, Rubio-Perez N, Silva CA, et al. Long-Term safety and efficacy of abatacept in children with juvenile idiopathic arthritis. Arthritis Rheum. 2010;62(6): 1792-802.
10. Yokota S, Imagawa T, Mori M, Miyamae T, Aihara Y, Takei S, et al. Efficacy and safety of tocilizumab in patients with systemiconset juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled, withdrawal phase III trial. Lancet. 2008; 371(9617):998-1006.
11. Giannini EH, Ilowite NT, Lovell DJ, Wallace CA, Rabinovich CE, Reiff A, et al. Long-Term safety and effectiveness of etanercept in children with selected categories of juvenile idiopathic arthritis. Arthritis Rheum. 2009;60(9):2794-804.
12. Quartier P, Taupin P, Bourdeaut F, Lemelle I, Pillet P, Bost M, et al. Efficacy of etanercept for the treatment of juvenile idiopathic arthritis according to the onset type. Arthritis Rheum. 2003;48(4):1093-101.
13. Lovell DJ, Giannini EH, Reiff A, Jones OY, Schneider R, Olson JC, et al. Long-Term efficacy and safety of etanercept in children with polyarticular-course juvenile rheumatoid arthritis -interim results from an ongoing multicenter, open-label, extended-Treatment trial. Arthritis Rheum. 2003;48(1):218-26.
14. Mori M, Takei S, Imagawa T, Imanaka H, Nerome Y, Kurosawa R, et al. Etanercept in the treatment of disease-modifying antirheumatic drug (DMARD) -refractory polyarticular juvenile idiopathic arthritis: experience from Japanese clinical trials. Mod Rheumatol. 2011;21(6):572-8.
15. Mori M, Takei S, Imagawa T, Imanaka H, Maeno N, Kurosawa R, et al. Pharmacokinetics, efficacy, and safety of short-Term (12 weeks) etanercept for methotrexate-refractory polyarticular juvenile idiopathic arthritis in Japan. Mod Rheumatol. 2005; 15(6):397-404.
16. Giannini E, Ruperto N, Ravelli A, Lovell D, Felson D, Martini A. Preliminary definition of improvement in juvenile arthritis. Arthritis Rheum. 1997;40(7):1202-9.
17. Lovell DJ, Reiff A, Jones OY, Schneider R, Nocton J, Stein LD, et al. Long-Term safety and efficacy of etanercept in children with polyarticular-course juvenile rheumatoid arthritis. Arthritis Rheum. 2006;54(6):1987-94.
18. Brewer EJ Jr, Bass J, Baum J, Cassidy JT, Fink C, Jacobs J, et al. Current proposed revision of JRA Criteria. JRA Criteria Subcommittee of the Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Section of The Arthritis Foundation. Arthritis Rheum. 1977;20((2 Suppl)):195-9.